---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-006659"
form_type: "8-K"
ticker: "GRCE"
cik: "0001444192"
company_name: "Grace Therapeutics, Inc."
filed_at: "2025-03-03T23:59:59+00:00"
generated_at: "2026-05-25T17:24:20.596964+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Grace Therapeutics updates corporate presentation with cash and runway guidance

## Summary
- Corporate presentation updated as of March 3, 2025; includes cash position and runway guidance.
- No specific financial figures (e.g., cash balance, runway duration) are available in the filing excerpt.
- Presentation furnished as Exhibit 99.1; further detail not disclosed in the 8-K text.

## SEC filing metadata
- accession: 0001140361-25-006659
- form_type: 8-K
- ticker: GRCE
- cik: 0001444192
- company_name: Grace Therapeutics, Inc.
- filed_at: 2025-03-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1444192/000114036125006659/0001140361-25-006659-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1444192/000114036125006659/ef20044669_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-006659
- JSON: https://secwatch.observer/filing/0001140361-25-006659.json
- Plain text: https://secwatch.observer/filing/0001140361-25-006659.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.